查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1879821

全球體外診斷市場

In Vitro Diagnostics
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計2030年，全球體外診斷市場規模將達1,343億美元。

全球體外診斷市場規模在2024年估計為1,097億美元，預計到2030年將達到1,343億美元，在分析期間（2024-2030年）內複合年成長率（CAGR）為3.4%。本報告分析的細分市場之一－試劑盒市場，預計複合年成長率為3.3%，到分析期末將達到863億美元。儀器細分市場預計在分析期間內複合年成長率為4.0%。

美國市場規模估計為291億美元，而中國市場預計將以5.2%的複合年成長率成長。

預計到2024年，美國體外診斷市場規模將達291億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到271億美元，在2024年至2030年的分析期間內，複合年成長率（CAGR）為5.2%。其他值得關注的區域市場包括日本和加拿大，預計在分析期內，它們的複合年成長率分別為2.3%和2.7%。在歐洲，德國預計將以約2.6%的複合年成長率成長。

全球體外診斷市場－主要市場趨勢與促進因素概述

為什麼體外診斷（IVD）已成為現代醫學中不可或缺的工具

體外診斷（IVD）已成為現代醫學中不可或缺的工具，在疾病的檢測、診斷、監測和治療決策中發揮關鍵作用。 IVD檢測分析血液、尿液、唾液和組織等生物檢體，在體外提供關於患者健康狀況的準確及時的資訊。這些檢測廣泛應用於各種醫療機構，包括醫院、臨床檢查室、診所和居家醫療機構，對於早期發現從感染疾病、癌症到心血管疾病和糖尿病等多種疾病至關重要。 IVD能夠在疾病早期（症狀出現之前）檢測到疾病，這對於預防性醫療保健至關重要，能夠實現及時的醫療干預，並有助於改善患者的治療效果。

全球體外診斷（IVD）市場正經歷強勁成長，其促進因素包括慢性病和感染疾病的增加、對個人化醫療日益成長的需求以及分子診斷技術的廣泛應用。隨著糖尿病、癌症和心血管疾病等疾病在全球範圍內負擔加重，以及新型感染疾病的出現，醫療機構越來越依賴體外診斷技術進行精準診斷和後續觀察。此外，基於患者基因資訊制定個人化治療方案的「個人化醫療」概念，進一步推動了伴隨診斷和基因檢測等先進體外診斷技術的應用。這些檢測有助於醫生為患者找到最有效的治療方法，最大限度地減少藥物副作用，並改善治療效果。隨著全球醫療體系持續重視疾病早期檢測和精準醫療，對創新、精準的體外診斷解決方案的需求預計將顯著成長。

哪些技術進步正在推動體外診斷市場的發展？

技術創新正在革新體外診斷市場，推動開發更精準、更有效率且更容易取得的診斷解決方案。其中最具影響力的創新之一是分子診斷技術的興起。聚合酵素鏈鎖反應(PCR)、次世代定序(NGS) 和數位 PCR 等技術透過分析遺傳物質，在分子層面檢測疾病。分子診斷具有高度的敏感度和特異性，使其成為檢測傳染性病原體、識別癌症相關基因突變以及評估各種疾病遺傳易感性的理想選擇。分子診斷能夠快速準確地提供結果，這正在改變 COVID-19、HIV 和肝炎等感染疾病的管理方式，因為早期準確檢測對於有效治療和控制疫情至關重要。此外，分子診斷技術也被整合到遺傳疾病、生殖醫學和產前檢測的常規篩檢計畫中，從而拓展了其在更廣泛的醫療領域的應用。

另一項變革性創新是即時檢測（POC​​）的出現，它能夠在患者照護現場或附近進行快速診斷檢測。 POC檢測設備體積小巧、操作簡便，可在數分鐘內提供結果，使醫護人員能夠立即做出臨床決策。這項技術在急診、農村和資源匱乏地區，以及需要即時介入的疾病（例如心臟病發作的心臟標記檢測和糖尿病的血糖監測）中尤其重要。對分散式護理和居家檢測日益成長的需求正在推動POC設備在慢性病管理、傳染病檢查和健康狀況監測中的應用。 POC檢測的便利性和快速性有助於提高病患滿意度，並支持轉型為以病人為中心的醫療保健模式。

人工智慧 (AI) 和機器學習 (ML) 的融合正在塑造體外診斷的未來。 AI 驅動的診斷平台正被用於分析複雜的資料集、識別模式，並從診斷結果中產生可操作的見解。這些技術能夠更準確地解讀檢測結果，降低診斷錯誤的機率，並為臨床決策提供支援。例如，AI 演算法在數位病理學和診斷成像中的應用，可以幫助病理學家更有效率地檢測異常情況並診斷癌症。機器學習模型也被用於開發預測性診斷，根據歷史數據和風險因素預測疾病的發生，從而促進早期療育。 AI 在體外診斷中的應用正在提高診斷準確性，簡化檢查室工作流程，並減輕醫護人員的負擔。隨著技術的進步，體外診斷市場預計將在自動化、互聯互通和數據分析領域迎來更多創新，實現更快、更可靠、更方便的診斷。

市場動態和監管標準如何影響體外診斷市場？

體外診斷市場受市場動態、監管標準和醫療保健趨勢等諸多因素的複雜交互作用影響，這些因素共同作用於產品的開發、上市和商業化。其中一個關鍵的市場促進因素是對預防保健和疾病早期檢測的日益重視。隨著全球醫療保健系統努力減輕慢性病負擔並改善患者預後，基於早期診斷檢測健康問題的預防保健策略日益受到關注。體外診斷醫療設備（IVD）在預防保健中發揮關鍵作用，它們能夠檢測與各種疾病相關的生物標記物，從而實現及時干預和治療。這一趨勢在北美和歐洲等已開發地區尤其明顯，這些地區的政府和醫療機構正在大力推廣癌症、糖尿病和心血管疾病等疾病的篩檢計畫。

監管標準和合規要求在體外診斷市場的發展中也發揮關鍵作用。美國食品藥物管理局(FDA)、歐洲藥品管理局 (EMA) 和其他區域性監管機構等，已製定嚴格的指南，用於診斷測試的開發、核准和商業化，以確保其安全性和有效性。遵守這些法規對於製造商成功進入市場並維護醫療服務提供者和患者的信任至關重要。監管環境正在不斷發展，以跟上體外診斷 (IVD) 技術（尤其是基因檢測和個人化醫療等領域）的快速創新步伐。例如，FDA 的突破性醫療器材計畫為滿足未被滿足的醫療需求的新型診斷設備提供了一條快速核准途徑，從而促進了創新測試的開發和核准。在歐洲，體外診斷醫療設備法規 (IVDR) 的實施提高了臨床證據和性能要求，影響了 IVD 產品的設計和開發。這些監管變化促使製造商投資於完善的臨床測試和品管體系，以滿足不斷變化的監管期望並確保合規性。

製造商競爭、價格壓力和醫療報銷政策等市場動態也會影響體外診斷市場。該市場的競爭格局呈現出大規模跨國公司、專業診斷公司和創新新Start-Ups並存的局面，它們各自提供針對特定臨床需求的各種體外診斷解決方案。各公司透過產品創新、整合數位健康技術以及提供包括儀器、試劑和軟體在內的綜合診斷解決方案來脫穎而出。價格壓力，尤其是在成本敏感市場，推動了對兼具高性能和具成本效益的診斷測試的需求。醫療報銷政策和支付方的核保決策會影響體外診斷測試的普及，因為報銷通常決定了這些產品的可近性和可負擔性。報銷環境因地區而異，並受到測試的臨床效用、替代診斷方案的可用性以及整體醫療預算等因素的影響。對於在體外診斷市場中運作的公司而言，了解這些市場動態和監管標準至關重要，這有助於它們滿足全球患者和醫療服務提供者的未滿足診斷需求，並拓展業務。

推動體外診斷市場擴張的關鍵成長要素有哪些？

全球體外診斷市場成長受多種關鍵因素驅動，包括慢性病和感染疾病的增加、個人化醫療需求的成長以及診斷技術的進步。其中一個關鍵成長要素是糖尿病、癌症和心血管疾病等慢性病發病率的上升，這使得對能夠早期發現、監測和管理這些疾病的診斷測試的需求顯著增加。隨著全球人口老化和這些疾病盛行率的持續上升，對能夠實現及時干預和個人化治療的體外診斷 (IVD) 解決方案的需求預計將進一步擴大。諸如用於糖尿病監測的糖化血紅蛋白 (HbA1c) 檢測、用於心臟病的心臟標誌物檢測以及用於腫瘤學的癌症生物標記檢測等 IVD 檢測正逐漸成為慢性病管理的標準工具，有助於改善患者預後並降低醫療成本。

另一個關鍵成長要素是人們對個人化醫療的日益重視，個人化醫療根據患者的基因和分子特徵制定個人化的治療策略。它利用伴隨診斷和基因檢測來識別最能從特定治療方法中受益的患者，從而改變疾病的治療和管理方式。這種方法在腫瘤學領域尤其有效，分子診斷技術用於識別基因突變，從而開發出比傳統治療方法更有效、副作用更少的標靶治療。對精準醫療的日益重視正在推動體外診斷（IVD）技術的應用，這些技術能夠提供全面的分子譜分析，並有助於制定個人化的治療方案。

診斷技術的不斷進步也推動了體外診斷市場的成長。就地檢驗、分子診斷、數位病理學和人工智慧驅動的診斷等創新技術能夠實現更早的疾病檢測、更精準的疾病進展監測以及更有效的個人化醫療。遠端患者監護和遠端醫療等數位健康技術的整合，透過實現持續的健康監測和支持傳統臨床環境以外的慢性病管理，拓展了體外診斷的應用範圍。此外，伴隨診斷在藥物研發和臨床試驗中的日益普及，也推動了對能夠根據患者對特定治療方法的反應可能性進行分層的體外診斷檢測的需求，從而有助於加速新藥研發並改善臨床試驗結果。

最後，體外診斷技術在新興治療領域和新興市場的應用不斷擴展，也推動了市場成長。在傳染病檢查領域，新冠肺炎疫情凸顯了體外診斷技術在疾病檢測和監測中的重要性，促使人們對診斷基礎設施和能力進行更多投資。針對SARS-CoV-2的快速靈敏診斷測試的開發，證明了體外診斷技術在應對疫情和公共衛生管理中的價值。在亞太和拉丁美洲等新興市場，醫療基礎設施的不斷改進、預防醫學意識的增強以及對醫療創新投入的增加，都在推動體外診斷解決方案的普及。隨著腫瘤學、感染疾病和個人化醫療等關鍵領域的需求持續成長，全球體外診斷市場預計將在技術進步、應用領域不斷拓展以及對早期檢測和精準醫療日益重視的推動下，保持持續成長。製造商們正不斷創新，以滿足不斷變化的醫療需求。

部分：

依產品/服務（試劑/試劑盒、儀器、數據管理軟體、服務）、按技術（免疫檢測/免疫化學、臨床化學、分子診斷、血液學、微生物學、凝血/止血、尿液分析、其他技術）、按最終用途（醫院檢查室、臨床檢查室、就地檢驗中心、學術機構、患者、其他最終用途）分類

受訪公司範例

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Becton, Dickinson &Company
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • DiaSorin SpA
  • Johnson &Johnson
  • Ortho Clinical Diagnostics
  • Qiagen NV
  • Roche Diagnostics（Schweiz）AG
  • Siemens AG
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.

人工智慧整合

我們正在利用檢驗的專家內容和人工智慧工具，改變您分析市場和競爭情報的方式。

Market Glass, Inc. 並沒有採用查詢LLM 或產業專用的SLM 的典型方法，而是建立了一個由世界各地領域專家精心策劃的內容庫，其中包括影片轉錄、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

在最新發布的報告中，Market Glass, Inc. 將關稅對地理市場的影響納入考量，並根據公司總部所在地、製造地以及進出口（成品和OEM產品）情況，預測企業競爭地位的變化。這種複雜多變的市場現實會從多個方面影響競爭對手，包括增加銷貨成本、降低盈利和重組供應鏈，同時也會影響微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 亞太其他地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP12549

Global In Vitro Diagnostics Market to Reach US$134.3 Billion by 2030

The global market for In Vitro Diagnostics estimated at US$109.7 Billion in the year 2024, is expected to reach US$134.3 Billion by 2030, growing at a CAGR of 3.4% over the analysis period 2024-2030. Reagents & Kits, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$86.3 Billion by the end of the analysis period. Growth in the Instruments segment is estimated at 4.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$29.1 Billion While China is Forecast to Grow at 5.2% CAGR

The In Vitro Diagnostics market in the U.S. is estimated at US$29.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$27.1 Billion by the year 2030 trailing a CAGR of 5.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.3% and 2.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.6% CAGR.

Global In Vitro Diagnostics Market - Key Trends & Drivers Summarized

Why Are In Vitro Diagnostics (IVD) Becoming Indispensable Tools for Modern Healthcare?

In vitro diagnostics (IVD) have emerged as indispensable tools in modern healthcare, playing a crucial role in disease detection, diagnosis, monitoring, and treatment decision-making. IVD tests analyze biological samples such as blood, urine, saliva, or tissue outside the human body to provide accurate and timely information about a patient’s health status. These tests are used across various healthcare settings, including hospitals, clinical laboratories, physician offices, and homecare environments, and are pivotal in the early detection of diseases, ranging from infectious diseases and cancer to cardiovascular conditions and diabetes. The ability of IVD to detect diseases in their early stages, often before symptoms appear, makes them essential for preventive care and for improving patient outcomes by enabling timely medical intervention.

The global IVD market is experiencing robust growth, driven by several factors, including the increasing prevalence of chronic and infectious diseases, the growing demand for personalized medicine, and the expanding applications of molecular diagnostics. With the rise in global disease burden-such as diabetes, cancer, cardiovascular diseases, and the emergence of new infectious diseases-healthcare providers are relying on IVD to diagnose conditions accurately and monitor disease progression. Additionally, the shift toward personalized medicine, which aims to tailor treatment strategies to individual patients based on their genetic makeup, is further driving the adoption of advanced IVD technologies such as companion diagnostics and genetic testing. These tests are helping physicians identify the most effective therapies for patients, minimizing adverse drug reactions and improving therapeutic outcomes. As healthcare systems across the globe continue to prioritize early disease detection and precision medicine, the demand for innovative and accurate IVD solutions is expected to rise significantly.

What Technological Advancements Are Driving the Evolution of the In Vitro Diagnostics Market?

Technological advancements are revolutionizing the in vitro diagnostics market, enabling the development of more accurate, efficient, and accessible diagnostic solutions. One of the most impactful innovations in this field is the rise of molecular diagnostics, which leverage technologies such as polymerase chain reaction (PCR), next-generation sequencing (NGS), and digital PCR to analyze genetic material and detect disease at a molecular level. Molecular diagnostics provide highly sensitive and specific results, making them ideal for detecting infectious agents, identifying genetic mutations associated with cancer, and assessing genetic predispositions to various conditions. The ability of molecular diagnostics to deliver rapid and precise results is transforming the management of infectious diseases, such as COVID-19, HIV, and hepatitis, where early and accurate detection is critical for effective treatment and containment. Furthermore, molecular diagnostics are being integrated into routine screening programs for genetic disorders, reproductive health, and prenatal testing, expanding their applicability across a broader spectrum of healthcare needs.

Another transformative innovation is the advent of point-of-care (POC) testing, which allows for rapid diagnostic testing at or near the site of patient care. POC testing devices are compact, user-friendly, and capable of delivering results within minutes, enabling healthcare providers to make immediate clinical decisions. This technology is especially valuable in emergency settings, rural or resource-limited areas, and for conditions requiring immediate intervention, such as cardiac markers for heart attacks or glucose monitoring for diabetes. The growing demand for decentralized healthcare and home-based testing is driving the adoption of POC devices for chronic disease management, infectious disease testing, and wellness monitoring. The convenience and speed offered by POC testing are enhancing patient satisfaction and supporting the shift toward more patient-centric healthcare models.

The integration of artificial intelligence (AI) and machine learning (ML) is also shaping the future of in vitro diagnostics. AI-driven diagnostic platforms are being used to analyze complex datasets, identify patterns, and generate actionable insights from diagnostic results. These technologies are enabling more accurate interpretations of test results, reducing the likelihood of diagnostic errors, and supporting clinical decision-making. For example, AI algorithms are being applied to digital pathology and imaging to assist pathologists in detecting abnormalities and diagnosing cancers more efficiently. Machine learning models are also being used to develop predictive diagnostics that can anticipate disease onset based on historical data and risk factors, facilitating earlier intervention. The use of AI in IVD is improving diagnostic accuracy, streamlining laboratory workflows, and reducing the burden on healthcare professionals. As technology continues to advance, the in vitro diagnostics market is expected to see further innovations in automation, connectivity, and data analytics, making diagnostics faster, more reliable, and more accessible.

How Are Market Dynamics and Regulatory Standards Influencing the In Vitro Diagnostics Market?

The in vitro diagnostics market is shaped by a complex interplay of market dynamics, regulatory standards, and healthcare trends that are influencing product development, adoption, and commercialization. One of the primary market drivers is the increasing emphasis on preventive healthcare and early disease detection. As healthcare systems globally strive to reduce the burden of chronic diseases and improve patient outcomes, there is a growing focus on preventive care strategies that rely on diagnostic tests to identify health issues at an early stage. IVD plays a critical role in preventive healthcare by enabling the detection of biomarkers associated with various diseases, allowing for timely intervention and treatment. This trend is particularly strong in developed regions such as North America and Europe, where governments and healthcare organizations are promoting screening programs for conditions such as cancer, diabetes, and cardiovascular diseases.

Regulatory standards and compliance requirements are also playing a crucial role in shaping the in vitro diagnostics market. Regulatory agencies such as the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and other regional bodies have established stringent guidelines for the development, approval, and commercialization of diagnostic tests to ensure their safety and efficacy. Compliance with these regulations is essential for manufacturers to gain market access and maintain the trust of healthcare providers and patients. The regulatory landscape is evolving to accommodate the rapid pace of innovation in IVD technologies, particularly in areas such as genetic testing and personalized medicine. For example, the FDA’s Breakthrough Devices Program provides an expedited pathway for novel diagnostic devices that address unmet medical needs, facilitating faster development and approval of innovative tests. In Europe, the implementation of the In Vitro Diagnostic Regulation (IVDR) is raising the bar for clinical evidence and performance requirements, influencing the design and development of IVD products. These regulatory changes are encouraging manufacturers to invest in robust clinical studies and quality management systems to ensure compliance and meet the evolving expectations of regulators.

Market dynamics such as competition among manufacturers, pricing pressures, and healthcare reimbursement policies are also impacting the in vitro diagnostics market. The competitive landscape is characterized by the presence of large multinational companies, specialized diagnostic firms, and innovative startups, each offering a range of IVD solutions tailored to specific clinical needs. Companies are differentiating themselves through product innovation, the integration of digital health technologies, and the ability to provide comprehensive diagnostic solutions that include devices, reagents, and software. Pricing pressures, particularly in cost-sensitive markets, are driving the demand for cost-effective diagnostic tests that offer high performance without compromising quality. Healthcare reimbursement policies and coverage decisions by payers are influencing the adoption of IVD tests, as reimbursement often determines the accessibility and affordability of these products. Reimbursement environments vary significantly across regions and are influenced by factors such as the clinical utility of the test, the availability of alternative diagnostic options, and the overall healthcare budget. Navigating these market dynamics and regulatory standards is essential for companies operating in the in vitro diagnostics market as they seek to expand their presence and address the unmet diagnostic needs of patients and healthcare providers worldwide.

What Are the Key Growth Drivers Fueling the Expansion of the In Vitro Diagnostics Market?

The growth in the global in vitro diagnostics market is driven by several key factors, including the increasing prevalence of chronic and infectious diseases, the rising demand for personalized medicine, and advancements in diagnostic technologies. One of the primary growth drivers is the rising incidence of chronic diseases such as diabetes, cancer, and cardiovascular disease, which is creating a significant need for diagnostic tests that can provide early detection, monitoring, and management. As the global population ages and the prevalence of these conditions continues to increase, the demand for IVD solutions that enable timely intervention and personalized treatment is expected to grow. IVD tests such as HbA1c for diabetes monitoring, cardiac markers for heart disease, and cancer biomarkers for oncology are becoming standard tools in chronic disease management, supporting better patient outcomes and reducing healthcare costs.

Another significant growth driver is the increasing focus on personalized medicine, which aims to tailor treatment strategies to individual patients based on their genetic and molecular profiles. Personalized medicine is transforming the approach to disease treatment and management by using companion diagnostics and genetic tests to identify patients who are most likely to benefit from specific therapies. This approach is particularly impactful in oncology, where molecular diagnostics are being used to identify genetic mutations and guide targeted therapies that are more effective and have fewer side effects than traditional treatments. The growing emphasis on precision medicine is driving the adoption of IVD technologies that can provide comprehensive molecular profiling and support the development of personalized treatment plans.

The ongoing advancement of diagnostic technologies is also fueling the growth of the in vitro diagnostics market. Innovations such as point-of-care testing, molecular diagnostics, digital pathology, and AI-driven diagnostics are making it possible to detect diseases earlier, monitor disease progression more accurately, and deliver personalized care more effectively. The integration of digital health technologies, such as remote patient monitoring and telemedicine, is expanding the reach of IVD by enabling continuous health monitoring and supporting the management of chronic conditions outside traditional healthcare settings. Additionally, the growing use of companion diagnostics in drug development and clinical trials is driving the demand for IVD tests that can stratify patients based on their likelihood of response to specific therapies, accelerating the development of new drugs and enhancing clinical trial outcomes.

Lastly, the expanding applications of in vitro diagnostics in new therapeutic areas and emerging markets are contributing to the growth of the market. In infectious disease testing, the COVID-19 pandemic has highlighted the critical role of IVD in disease detection and surveillance, leading to increased investment in diagnostic infrastructure and capabilities. The development of rapid and highly sensitive diagnostic tests for SARS-CoV-2 has demonstrated the value of IVD in pandemic response and public health management. In emerging markets such as Asia-Pacific and Latin America, the growing healthcare infrastructure, rising awareness of preventive healthcare, and increasing investment in healthcare innovation are driving the adoption of IVD solutions. As demand from key sectors such as oncology, infectious diseases, and personalized medicine continues to rise, and as manufacturers innovate to meet evolving healthcare needs, the global in vitro diagnostics market is expected to witness sustained growth, driven by advancements in technology, expanding applications, and the increasing emphasis on early detection and precision medicine.

SCOPE OF STUDY:

The report analyzes the In Vitro Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product & Service (Reagents & Kits, Instruments, Data Management Software, Services); Technology (Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis, Other Technologies); End-Use (Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 58 Featured) -

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Becton, Dickinson & Company
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • DiaSorin SpA
  • Johnson & Johnson
  • Ortho Clinical Diagnostics
  • Qiagen NV
  • Roche Diagnostics (Schweiz) AG
  • Siemens AG
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • Global Economic Update
    • In Vitro Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Expansion of Infectious Disease Testing and Personalized Medicine Spurs Adoption of IVD Solutions
    • Growth in Focus on Rapid, Accurate Diagnostic Solutions Expands Addressable Market for In Vitro Diagnostics
    • Growth in Use of IVD for Cancer Screening and Genetic Testing Expands Market Opportunities
    • Technological Integration for AI-driven Diagnostics and Digital Pathology Expands Market Potential
    • Growth in Demand for Point-of-care IVD Devices in Home Care and Ambulatory Settings Fuels Market Expansion
    • Growth in Use of IVD for Companion Diagnostics in Oncology Expands Market Reach
    • Growth in Use of IVD for Cardiovascular, Diabetes, and Infectious Disease Management Fuels Market Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World In Vitro Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for In Vitro Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for In Vitro Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for In Vitro Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Reagents & Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Data Management Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Data Management Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Data Management Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Immunoassay / Immunochemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Immunoassay / Immunochemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Immunoassay / Immunochemistry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Clinical Chemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Clinical Chemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Clinical Chemistry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Hematology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Hematology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Hematology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Microbiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Microbiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Microbiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Coagulation & Hemostasis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Coagulation & Hemostasis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Coagulation & Hemostasis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Urinalysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Urinalysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Urinalysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Hospital Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Hospital Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: World 15-Year Perspective for Hospital Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Clinical Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Clinical Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: World 15-Year Perspective for Clinical Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 47: World Recent Past, Current & Future Analysis for Point-Of-Care Testing Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 48: World Historic Review for Point-Of-Care Testing Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: World 15-Year Perspective for Point-Of-Care Testing Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 50: World Recent Past, Current & Future Analysis for Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: World Historic Review for Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: World 15-Year Perspective for Academic Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 53: World Recent Past, Current & Future Analysis for Patients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 54: World Historic Review for Patients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: World 15-Year Perspective for Patients by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 56: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 57: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • In Vitro Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 59: USA Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: USA Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: USA 15-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2015, 2025 & 2030
    • TABLE 62: USA Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: USA Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: USA 15-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 65: USA Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: USA Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: USA 15-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 68: Canada Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Canada Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Canada 15-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2015, 2025 & 2030
    • TABLE 71: Canada Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Canada Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Canada 15-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 74: Canada Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Canada Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Canada 15-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • In Vitro Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 77: Japan Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Japan Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Japan 15-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2015, 2025 & 2030
    • TABLE 80: Japan Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Japan Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Japan 15-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 83: Japan Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Japan Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Japan 15-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • In Vitro Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 86: China Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: China Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: China 15-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2015, 2025 & 2030
    • TABLE 89: China Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: China Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: China 15-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 92: China Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: China Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: China 15-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • In Vitro Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 95: Europe Recent Past, Current & Future Analysis for In Vitro Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 96: Europe Historic Review for In Vitro Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Europe 15-Year Perspective for In Vitro Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 98: Europe Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Europe Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Europe 15-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2015, 2025 & 2030
    • TABLE 101: Europe Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Europe Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Europe 15-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 104: Europe Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Europe Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Europe 15-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • In Vitro Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 107: France Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: France Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: France 15-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2015, 2025 & 2030
    • TABLE 110: France Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: France Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: France 15-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 113: France Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: France Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: France 15-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • In Vitro Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 116: Germany Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Germany Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Germany 15-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2015, 2025 & 2030
    • TABLE 119: Germany Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Germany Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Germany 15-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 122: Germany Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Germany Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Germany 15-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 125: Italy Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Italy Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Italy 15-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2015, 2025 & 2030
    • TABLE 128: Italy Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Italy Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Italy 15-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 131: Italy Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Italy Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Italy 15-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • In Vitro Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 134: UK Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: UK Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: UK 15-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2015, 2025 & 2030
    • TABLE 137: UK Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: UK Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: UK 15-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 140: UK Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: UK Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: UK 15-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 143: Spain Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Spain Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Spain 15-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2015, 2025 & 2030
    • TABLE 146: Spain Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Spain Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Spain 15-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 149: Spain Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Spain Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Spain 15-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 152: Russia Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Russia Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Russia 15-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2015, 2025 & 2030
    • TABLE 155: Russia Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Russia Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Russia 15-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 158: Russia Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Russia Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Russia 15-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 161: Rest of Europe Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Europe Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Europe 15-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2015, 2025 & 2030
    • TABLE 164: Rest of Europe Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Europe Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Europe 15-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 167: Rest of Europe Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Europe Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Rest of Europe 15-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • In Vitro Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 170: Asia-Pacific Recent Past, Current & Future Analysis for In Vitro Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 171: Asia-Pacific Historic Review for In Vitro Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Asia-Pacific 15-Year Perspective for In Vitro Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 173: Asia-Pacific Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Asia-Pacific Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Asia-Pacific 15-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2015, 2025 & 2030
    • TABLE 176: Asia-Pacific Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Asia-Pacific Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Asia-Pacific 15-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 179: Asia-Pacific Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Asia-Pacific Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Asia-Pacific 15-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • In Vitro Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 182: Australia Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Australia Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Australia 15-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2015, 2025 & 2030
    • TABLE 185: Australia Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Australia Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Australia 15-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 188: Australia Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Australia Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Australia 15-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • In Vitro Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 191: India Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: India Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: India 15-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2015, 2025 & 2030
    • TABLE 194: India Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: India Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: India 15-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 197: India Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: India Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: India 15-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 200: South Korea Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: South Korea Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: South Korea 15-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2015, 2025 & 2030
    • TABLE 203: South Korea Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: South Korea Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: South Korea 15-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 206: South Korea Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: South Korea Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: South Korea 15-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 209: Rest of Asia-Pacific Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Rest of Asia-Pacific Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Rest of Asia-Pacific 15-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2015, 2025 & 2030
    • TABLE 212: Rest of Asia-Pacific Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Rest of Asia-Pacific Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Rest of Asia-Pacific 15-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 215: Rest of Asia-Pacific Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Rest of Asia-Pacific Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Rest of Asia-Pacific 15-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • In Vitro Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 218: Latin America Recent Past, Current & Future Analysis for In Vitro Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 219: Latin America Historic Review for In Vitro Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Latin America 15-Year Perspective for In Vitro Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 221: Latin America Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Latin America Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Latin America 15-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2015, 2025 & 2030
    • TABLE 224: Latin America Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Latin America Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Latin America 15-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 227: Latin America Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Latin America Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Latin America 15-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 230: Argentina Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Argentina Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Argentina 15-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2015, 2025 & 2030
    • TABLE 233: Argentina Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Argentina Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Argentina 15-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 236: Argentina Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Argentina Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Argentina 15-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 239: Brazil Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Brazil Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Brazil 15-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2015, 2025 & 2030
    • TABLE 242: Brazil Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Brazil Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Brazil 15-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 245: Brazil Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Brazil Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Brazil 15-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 248: Mexico Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Mexico Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Mexico 15-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2015, 2025 & 2030
    • TABLE 251: Mexico Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Mexico Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Mexico 15-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 254: Mexico Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Mexico Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Mexico 15-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 257: Rest of Latin America Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Rest of Latin America Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Rest of Latin America 15-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2015, 2025 & 2030
    • TABLE 260: Rest of Latin America Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Rest of Latin America Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Rest of Latin America 15-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 263: Rest of Latin America Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Rest of Latin America Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Rest of Latin America 15-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • In Vitro Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 266: Middle East Recent Past, Current & Future Analysis for In Vitro Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 267: Middle East Historic Review for In Vitro Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Middle East 15-Year Perspective for In Vitro Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 269: Middle East Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Middle East Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Middle East 15-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2015, 2025 & 2030
    • TABLE 272: Middle East Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Middle East Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Middle East 15-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 275: Middle East Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Middle East Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: Middle East 15-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 278: Iran Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Iran Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: Iran 15-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2015, 2025 & 2030
    • TABLE 281: Iran Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Iran Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: Iran 15-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 284: Iran Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Iran Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: Iran 15-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 287: Israel Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Israel Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: Israel 15-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2015, 2025 & 2030
    • TABLE 290: Israel Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Israel Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: Israel 15-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 293: Israel Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Israel Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: Israel 15-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 296: Saudi Arabia Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Saudi Arabia Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: Saudi Arabia 15-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2015, 2025 & 2030
    • TABLE 299: Saudi Arabia Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Saudi Arabia Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Saudi Arabia 15-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 302: Saudi Arabia Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Saudi Arabia Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 304: Saudi Arabia 15-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 305: UAE Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: UAE Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 307: UAE 15-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2015, 2025 & 2030
    • TABLE 308: UAE Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 309: UAE Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 310: UAE 15-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 311: UAE Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 312: UAE Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 313: UAE 15-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 314: Rest of Middle East Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Rest of Middle East Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 316: Rest of Middle East 15-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2015, 2025 & 2030
    • TABLE 317: Rest of Middle East Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 318: Rest of Middle East Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 319: Rest of Middle East 15-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 320: Rest of Middle East Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 321: Rest of Middle East Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 322: Rest of Middle East 15-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • In Vitro Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 323: Africa Recent Past, Current & Future Analysis for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 324: Africa Historic Review for In Vitro Diagnostics by Product & Service - Reagents & Kits, Instruments, Data Management Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 325: Africa 15-Year Perspective for In Vitro Diagnostics by Product & Service - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments, Data Management Software and Services for the Years 2015, 2025 & 2030
    • TABLE 326: Africa Recent Past, Current & Future Analysis for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 327: Africa Historic Review for In Vitro Diagnostics by Technology - Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 328: Africa 15-Year Perspective for In Vitro Diagnostics by Technology - Percentage Breakdown of Value Sales for Immunoassay / Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 329: Africa Recent Past, Current & Future Analysis for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 330: Africa Historic Review for In Vitro Diagnostics by End-Use - Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 331: Africa 15-Year Perspective for In Vitro Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories, Clinical Laboratories, Point-Of-Care Testing Centers, Academic Institutes, Patients and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION